ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000855.1|Ectoine_1 # 2 # 367 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.481	BGC0000855.1|Ectoine_1 	2	367	+	Loose	300	23.0978	dfrA3	34.29	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ACGTTAAATTACGGCCATAACAACCCGGTCTTTAAAGAGAAGCTTTTGGACTACATCCATAGCGATGGCATTACCCACGGTTTGGACTTGCATACCAAAGCCAAGGGCGAATTTCTGGAAACCTTCAATGAAAAAATTCTCAAACCGAGAGGTTTGGAGTATGTCATGCAGTTTACCGGGCCTACCGGAACCAATGCGGTCGAAGCGGCACTGAAATTGGCGCGTAACGTGACCGGACGGGAAAATGTTGTTTCCTTTACCAATGGCTTTCACGGCGCCCGAGGACGGCATGGCCGTTCATCGTTTGATTGCGCAATGTCCTCCGCTGGACCCCAATTCCATTTATTGCAATTTATTGCAATGTAG	TLNYGHNNPVFKEKLLDYIHSDGITHGLDLHTKAKGEFLETFNEKILKPRGLEYVMQFTGPTGTNAVEAALKLARNVTGRENVVSFTNGFHGARGRHGRSSFDCAMSSAGPQFHLLQFIAM	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	74.69	gnl|BL_ORD_ID|480|hsp_num:0	511		
BGC0000855.1|Ectoine_2 # 788 # 2098 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.500	BGC0000855.1|Ectoine_2 	788	2098	+	Loose	2000	26.5646	Staphylococcus aureus mupA conferring resistance to mupirocin	21.57	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGAAAATTTTTGACGAGATCGAATCTGAAGTACAAAGTTATGCGCGTTCATTTCCGCGCATCTTCAACAAAGCGAAAGGAGAATTTCTCTATGACGAGGAGGGTAACGAATATATCGACTTTCTCGCCGGAGCCGGAACGTTAAATTACGGCCATAACAACCCGGTCTTTAAAGAGAAGCTTTTGGACTACATCCATAGCGATGGCATTACCCACGGCTTGGACTTGCATACCAAAGCCAAGGGCGAATTTCTGGAAACCTTCAATGAAAAAATTCTCAAACCGAGAGGTTTGGAGTATGTCATGCAGTTTACCGGGCCTACCGGAACCAATGCGGTCGAAGCGGCACTGAAATTGGCGCGTAACGTGACCGGACGGGAAAATGTTGTTTCCTTTACCAATGGCTTTCACGGCGTCAGCTTGGGCTCTTTGGCGGCGACCGGCAATTCGCATCACCGAGGCGCGGCAGGCGTGAGTTTAAACGGCACCAGTAGAATGCCGTATGACGGTTATTTAGGCGACGACATCGACACGACCGCCTATTTAGATAAGGTGCTTTCCGATTCCAGTAGTGGTGTCGATTTGCCTGCGGCTGTCATCGTCGAGACCGTTCAAGGCGAGGGCGGTATTAACGCGGCAAGTTTCGAGTGGCTGAAAAATCTGGACCAGGTGTGTAAAAAGCACGGCGTATTGCTGATTGTCGACGATATTCAAGCCGGCTGCGGACGTACCGGAACGTATTTCAGTTTTGAAGAGGTCGGGATTTATCCGGATATCGTGACCTTGTCTAAATCGCTCGGCGGTTACGGCTTGCCTTTTGCCGTGGTGCTGATCCGGCCGGAGCTTGATCAATGGAAGCCGGGCGAACACAACGGAACGTTTCGCGGCAATAATTTTGCCTTTGTCACGGCCAAAGCCGCAATCGACCATTATTGGTCCGATAACCGTTTCGCCGATCAAATCAAGCAAAAAGGCGAGTATGTTTCGAGCCGCTTGAATAAGATCGTCGATCTATATGGCGAAGGTAATTTCACAACGCGTGGGCGAGGCATGTTTCAAGGCATCAATTGCGTCAATGGCGATTTGGCCGGAAAAATCACGCGTCGAGCGTTTCAATTGGGCTTGGTGATCGAAACCAGCGGTGCCGACGATCATGTCGTCAAGTTTTTGTGTCCGTTGACGATAGCCGAGGCAAGCCTCAAGAAAGGCATCGACATCGTCGAGCAAGCGATCAAGGAAGTCTGTGCCAAGGAGAGCAGCATTCCTCAGGAAAAAAATTATTTTGAGGCGGACTATAAACTCGCCAGTTGA	MKIFDEIESEVQSYARSFPRIFNKAKGEFLYDEEGNEYIDFLAGAGTLNYGHNNPVFKEKLLDYIHSDGITHGLDLHTKAKGEFLETFNEKILKPRGLEYVMQFTGPTGTNAVEAALKLARNVTGRENVVSFTNGFHGVSLGSLAATGNSHHRGAAGVSLNGTSRMPYDGYLGDDIDTTAYLDKVLSDSSSGVDLPAAVIVETVQGEGGINAASFEWLKNLDQVCKKHGVLLIVDDIQAGCGRTGTYFSFEEVGIYPDIVTLSKSLGGYGLPFAVVLIRPELDQWKPGEHNGTFRGNNFAFVTAKAAIDHYWSDNRFADQIKQKGEYVSSRLNKIVDLYGEGNFTTRGRGMFQGINCVNGDLAGKITRRAFQLGLVIETSGADDHVVKFLCPLTIAEASLKKGIDIVEQAIKEVCAKESSIPQEKNYFEADYKLAS	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	42.58	gnl|BL_ORD_ID|2125|hsp_num:0	2270		
BGC0000855.1|Ectoine_3 # 2350 # 2673 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.472	BGC0000855.1|Ectoine_3 	2350	2673	+	Loose	700	25.0238	CMY-54	64.71	3002065	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGCTTTTGAAAGACGACAATATGGGGTTTTCTTTTCACATCACGACGATTTATCAAGGTGCGGATTTTCAAATGCATTATCAAAATCATTTGGAATCGGTGTATTGCATCTCGGGCGAGGGTGAAGTTGAAACTCTTGACGACGGCAAGGTTTATCCGATTGGCCCGGGAACGCTTTATATCTTAGATCGACACGACAAACATATCTTGCGCGCCTTCAAGGAAATGACCATGGCCTGCGTCTTTAATCCGCCGCTCAACGGTAAGGAAGTACACAATGCCGAGGGGGCTTACGAACTCGATGCCGAAGCGCTGGAGGGGTAA	MLLKDDNMGFSFHITTIYQGADFQMHYQNHLESVYCISGEGEVETLDDGKVYPIGPGTLYILDRHDKHILRAFKEMTMACVFNPPLNGKEVHNAEGAYELDAEALEG	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLELDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	27.94	gnl|BL_ORD_ID|639|hsp_num:0	680		
BGC0000855.1|Ectoine_4 # 2840 # 3070 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.524	BGC0000855.1|Ectoine_4 	2840	3070	+	Loose	850	21.9422	OpmB	31.03	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCAAAACGTTGCTGATTTTATGGCTCATGCTGCCGGTAGCCGTTAAGGCCGAAACCGACGTGCCTGCGGAAAGCGAGCCGGAGACGATAGTCGAAGAAGCCTTGGAGGCCCTGGACAAACCGCTCTATAGTCCGTTCATCGAGCGTTATATATTGGATGAGCTCAAGCAGCTGCGCGTGGACCTGGCCCGCGCAAAGAAACGAATTATTGCAGCAAATTTTGGATAG	MLKTLLILWLMLPVAVKAETDVPAESEPETIVEEALEALDKPLYSPFIERYILDELKQLRVDLARAKKRIIAANFG	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	15.26	gnl|BL_ORD_ID|2374|hsp_num:0	2716		
BGC0000855.1|Ectoine_5 # 3343 # 3558 # 1 # ID=1_5;partial=01;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.546	BGC0000855.1|Ectoine_5 	3343	3558	+	Loose	750	23.483	tet(50)	37.93	3004584	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCAGTCATTATGGTTGCGAGCCGGGCAGGCGAGCAGTCTGAGCAACAAGATCGCGATTTACGATCAGATTTTGCGCTTGCGCCCCGAGGATTGCGAGGCGCTGACCTATAAGGCCGATGCGGTGCTCGATCTAGGTGAGCCTCAGTGGGCCGCGAATTTATGCCAGCAAGCGTTGAAAATCGATCCGGAAAACGGCCATGCATTCTATCAATTG	MQSLWLRAGQASSLSNKIAIYDQILRLRPEDCEALTYKADAVLDLGEPQWAANLCQQALKIDPENGHAFYQL	MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE	18.56	gnl|BL_ORD_ID|2780|hsp_num:0	3287		
